Fenofibrate News and Research

RSS
Fenofibrate is a drug used to treat high levels of cholesterol and triglycerides in the blood. Fenofibrate is being studied in the treatment of advanced cancers in young patients and in the treatment of other conditions. It is a type of antilipidemic agent. Also called Lofibra and TriCor.
FDA-approved drug encourages sensory neurons to regrow after injury

FDA-approved drug encourages sensory neurons to regrow after injury

Lipid-lowering drug TriCor dramatically cuts treatment time for severe COVID-19 patients

Lipid-lowering drug TriCor dramatically cuts treatment time for severe COVID-19 patients

Eldelumab and Fenofibrate show potential for COVID-19

Eldelumab and Fenofibrate show potential for COVID-19

Chemical engineers devise a simpler process to incorporate hydrophobic drugs into tablets

Chemical engineers devise a simpler process to incorporate hydrophobic drugs into tablets

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Intensive interventions in type 2 diabetes reduce risk of cardiovascular autonomic neuropathy

Intensive interventions in type 2 diabetes reduce risk of cardiovascular autonomic neuropathy

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

Cholesterol-lowering drugs show promise to lower COVID-19's threat

Cholesterol-lowering drugs show promise to lower COVID-19's threat

LMRI scientists discover cause of debilitating eye disease

LMRI scientists discover cause of debilitating eye disease

First genetic cause for a rare eye disease discovered

First genetic cause for a rare eye disease discovered

TSRI chemists invent new method that simplifies late-stage modification of drug molecules

TSRI chemists invent new method that simplifies late-stage modification of drug molecules

Fenofibrate drug may reduce risk of cardiovascular events in patients with type 2 diabetes

Fenofibrate drug may reduce risk of cardiovascular events in patients with type 2 diabetes

ACCORDION study shows lowering blood glucose can reduce progression of diabetic retinopathy

ACCORDION study shows lowering blood glucose can reduce progression of diabetic retinopathy

Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

Fenofibrate benefits in diabetic retinopathy mediated through PPARα

Fenofibrate benefits in diabetic retinopathy mediated through PPARα

Promising new therapeutic strategy for chronic kidney disease

Promising new therapeutic strategy for chronic kidney disease

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Epicure project: an interview with Frédéric Cren

Epicure project: an interview with Frédéric Cren

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014